New York Life Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
22,336
+67
| +0.3% | +$8.42K | 0.03% | 457 |
|
|
2025
Q1 | $3.05M | Sell |
22,269
-189
| -0.8% | -$25.9K | 0.03% | 436 |
|
|
2024
Q4 | $3.43M | Sell |
22,458
-124
| -0.5% | -$19K | 0.03% | 419 |
|
|
2024
Q3 | $4.38M | Sell |
22,582
-385
| -2% | -$74.6K | 0.04% | 384 |
|
|
2024
Q2 | $5.32M | Buy |
22,967
+339
| +1% | +$78.6K | 0.05% | 319 |
|
|
2024
Q1 | $4.88M | Sell |
22,628
-690
| -3% | -$149K | 0.05% | 346 |
|
|
2023
Q4 | $6.03M | Sell |
23,318
-8,777
| -27% | -$2.27M | 0.06% | 273 |
|
|
2023
Q3 | $8.25M | Sell |
32,095
-1,195
| -4% | -$307K | 0.09% | 205 |
|
|
2023
Q2 | $9.48M | Sell |
33,290
-311
| -0.9% | -$88.6K | 0.1% | 193 |
|
|
2023
Q1 | $9.34M | Buy |
33,601
+10,028
| +43% | +$2.79M | 0.1% | 200 |
|
|
2022
Q4 | $6.53M | Sell |
23,573
-561
| -2% | -$155K | 0.07% | 262 |
|
|
2022
Q3 | $6.44M | Sell |
24,134
-398
| -2% | -$106K | 0.08% | 253 |
|
|
2022
Q2 | $5M | Buy |
+24,532
| New | +$5M | 0.06% | 308 |
|